The Food and Drug Administration is asking a judge to give it 75 years to produce data concerning the Pfizer and BioNTech vaccine, up 20 years from a previous request.

The agency, known as the FDA, told the court it can work faster than its previously 
proposed 500-pages-per-month-rate. But it also said there are over 59,000 more 
pages than mentioned in an earlier filing.

That discovery, and a desire to make sure it can work on other Freedom of 
Information Act requests at the same time, prompted the fresh request to the judge 
to allow production of roughly 12,000 pages by Jan. 31, 2022, and 500 pages 
per month thereafter.

That timeline would take it until at least 2096, Aaron Siri, a lawyer working on 
the case, said in a blog post.

“If you find what you are reading difficult to believe—that is because it is dystopian 
for the government to give Pfizer billions, mandate Americans to take its product, 
prohibit Americans from suing for harms, but yet refuse to let Americans see the 
data underlying its licensure,” Siri said.

The case was brought on behalf of the Public Health and Medical Professionals 
for Transparency, which said the FDA was not complying with its request for 
data in a timely manner.

The group includes Dr. Carole Browner, a research professor at the University 
of California, Los Angeles’ David Geffen School of Medicine; Peter Doshi, 
an associate professor at the University of Maryland’s School of Pharmacy, and 
Dr. Harvey Risch, a professor of epidemiology at the Yale School of 
Public Health.

The group says that the data should be made public quickly because the FDA spent 
just 108 days reviewing it before granting emergency use authorization to the 
Pfizer-BioNTech vaccine.

The matter is more urgent because millions of Americans are being mandated to 
take the shot or face repercussions, such as a loss of access to businesses and 
termination.

The Pfizer jab is the only one that has been approved by drug regulators. 
Approvals mean products have met a higher threshold of safety and effectiveness 
than those given emergency clearance.

“The entire purpose of FOIA is government transparency. In multiple recent 
cases, in upholding the FOIA’s requirement to ‘make the records promptly 
available,’ courts have required agencies, including the FDA, to produce 
10,000 or more pages per month, and those cases did not involve a request 
nearly this important–i.e., the data underlying licensure of a liability-free 
product that the federal government requires nearly all Americans to receive,” 
Siri said.

“As the present pandemic rages on, independent review of these documents 
by outside scientists is urgently needed to assist with addressing the shortcomings 
and issues with the response to the pandemic to date.”

The FDA said its Center for Biologics Evaluation and Research maintains the 
records sought by the plaintiff but only has 10 staff members, and two of them 
are new, leaving them slower in processing pages than the other workers.

Each line of each page must be reviewed to ensure proper redactions are applied,
 the filing says.

Additionally, a faster rate than that requested would divert “significant resources
 away from the processing of other FOIA requests that are also in litigation,” and 
requests that came in before the request in question, the agency said, adding, 
“In sum, FDA’s proposed processing schedule is fair to plaintiff.”

FDA Says It Now Needs 75 Years to Fully Release Pfizer COVID-19 Vaccine Data (blacklistednews.com)